It will be necessary to perform a RCT to determine if keeping Erlotinib + adding chemotherapy after progression of disease will provide any benefit compared to patient that switched directly to chemotherapy alone.
Regarding the second question: If the patient has a flare that is causing significant morbidity or potential mortality I would no doubt at all to put him back on Erlotinib.